Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Ono-9780307 | 856691-44-6 | 99.9% | 521.6 g/mol | C30H35NO7 | 10 MG
SDP

Catalog No. 5000226999
Encompass_Preferred

ONO-9780307 is a synthetic antagonist of lysophosphatidic acid receptor 1 (LPA1) used as a research tool. It exhibits reported potency (IC50 ≈ 2.7 nM), has molecular formula C30H35NO7, and molecular weight 521.6 g/mol. Supplied as a high-purity research sample for in vitro and structural biology studies; not for human or veterinary use.

  • Specific LPA1 antagonist with reported IC50 ≈ 2.7 nM.
  • Used in structural biology and pharmacology research.
  • High purity suitable for biochemical and biophysical assays.
  • Provided as a 10 mg solid for laboratory use.
  • For research use only; not for human or veterinary administration.

Catalog No. 50-002-26999 Supplier Medchemexpress LLC Supplier No. HY11744410MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ONO-9780307 is a synthetic antagonist of lysophosphatidic acid receptor 1 (LPA1) used as a research tool. It exhibits reported potency (IC50 ≈ 2.7 nM), has molecular formula C30H35NO7, and molecular weight 521.6 g/mol. Supplied as a high-purity research sample for in vitro and structural biology studies; not for human or veterinary use.

  • Specific LPA1 antagonist with reported IC50 ≈ 2.7 nM.
  • Used in structural biology and pharmacology research.
  • High purity suitable for biochemical and biophysical assays.
  • Provided as a 10 mg solid for laboratory use.
  • For research use only; not for human or veterinary administration.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.